Adjunctive Cilostazol to Dual Antiplatelet Therapy to Enhance Mobilization of Endothelial Progenitor Cell in Patients with Acute Myocardial Infarction: A Randomized, Placebo-Controlled EPISODE Trial

Background: Endothelial progenitor cells (EPCs) have the potential to protect against atherothrombotic event occurrences. There are no data to evaluate the impact of cilostazol on EPC levels in high-risk patients. Methods: We conducted a randomized, double-blind, placebo-controlled trial to assess t...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Yongwhi, Kim, Jin Hyun, Kim, Tae Ho, Koh, Jin-Sin, Hwang, Seok-Jae, Hwang, Jin-Yong, Jeong, Young-Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356664/
https://www.ncbi.nlm.nih.gov/pubmed/32492942
http://dx.doi.org/10.3390/jcm9061678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356664/
https://www.ncbi.nlm.nih.gov/pubmed/32492942
http://dx.doi.org/10.3390/jcm9061678

Ejemplares similares